Cannabinoids in chronic non-cancer pain medicine: moving from the bench to the bedside.
作者信息
Meng H, Deshpande A
机构信息
University of Toronto, Toronto, ON, Canada.
University Health Network, Toronto, ON, Canada.
出版信息
BJA Educ. 2020 Sep;20(9):305-311. doi: 10.1016/j.bjae.2020.05.002. Epub 2020 Jul 21.
Abstract
摘要
相似文献
1
Cannabinoids in chronic non-cancer pain medicine: moving from the bench to the bedside.慢性非癌性疼痛医学中的大麻素：从实验台走向临床应用
BJA Educ. 2020 Sep;20(9):305-311. doi: 10.1016/j.bjae.2020.05.002. Epub 2020 Jul 21.
2
, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back.内源性大麻素系统与免疫：从临床到基础研究的探索。
Int J Mol Sci. 2020 Jun 23;21(12):4448. doi: 10.3390/ijms21124448.
3
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.大麻素治疗多发性硬化症症状：证据现状。
Curr Neurol Neurosci Rep. 2018 Jun 19;18(8):50. doi: 10.1007/s11910-018-0859-x.
4
Cannabis and cannabinoids: pharmacology and rationale for clinical use.大麻与大麻素：药理学及临床应用原理
Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. doi: 10.1159/000057150.
5
State of the science: cannabis and cannabinoids in palliative medicine-the potential.科学现状：姑息医学中的大麻和大麻素——潜力。
BMJ Support Palliat Care. 2021 Sep;11(3):299-302. doi: 10.1136/bmjspcare-2021-002888. Epub 2021 Apr 26.
6
Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.大麻素在治疗多发性硬化症的疼痛和痉挛方面的应用
Curr Opin Investig Drugs. 2002 Jun;3(6):859-64.
7
Cannabis and Cannabinoids for Chronic Pain.大麻和大麻素治疗慢性疼痛。
Curr Rheumatol Rep. 2017 Oct 5;19(11):67. doi: 10.1007/s11926-017-0693-1.
8
Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain.理解医用大麻和基于大麻的药物治疗慢性非癌症疼痛的证据。
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):135-144. doi: 10.1007/s00406-018-0960-9. Epub 2019 Jan 11.
9
Medical cannabis and cannabinoids in rheumatology: where are we now?医学大麻和大麻素在风湿病学中的应用：我们现在处于什么位置？
Expert Rev Clin Immunol. 2019 Oct;15(10):1019-1032. doi: 10.1080/1744666X.2019.1665997.
10
Cannabinoids and Pain: New Insights From Old Molecules.大麻素与疼痛：旧分子带来的新见解
Front Pharmacol. 2018 Nov 13;9:1259. doi: 10.3389/fphar.2018.01259. eCollection 2018.
引用本文的文献
1
How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges.可生物降解聚合物如何成为大麻素的有效药物传递系统？前景与挑战。
Int J Nanomedicine. 2024 May 22;19:4607-4649. doi: 10.2147/IJN.S458907. eCollection 2024.
2
Tetrahydrocannabinol and Cannabidiol for Pain Treatment-An Update on the Evidence.用于疼痛治疗的四氢大麻酚和大麻二酚——证据更新
Biomedicines. 2024 Jan 29;12(2):307. doi: 10.3390/biomedicines12020307.
3
Differential Effects of Cannabidiol and a Novel Cannabidiol Analog on Oxycodone Place Preference and Analgesia in Mice: an Opioid Abuse Deterrent with Analgesic Properties.大麻二酚和一种新型大麻二酚类似物对小鼠羟考酮觅药行为和镇痛作用的差异影响：具有阿片类药物滥用抑制和镇痛特性的药物。
Cannabis Cannabinoid Res. 2022 Dec;7(6):804-813. doi: 10.1089/can.2021.0050. Epub 2021 Dec 24.
本文引用的文献
1
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.合法与非法娱乐用大麻市场中大麻使用的流行情况及形式。
Int J Drug Policy. 2020 Feb;76:102658. doi: 10.1016/j.drugpo.2019.102658. Epub 2020 Jan 9.
2
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.大麻二酚通过双向调控 ERK1-2 磷酸化拮抗腹侧海马区 Δ-9-四氢大麻酚的精神副作用。
J Neurosci. 2019 Oct 30;39(44):8762-8777. doi: 10.1523/JNEUROSCI.0708-19.2019. Epub 2019 Sep 30.
3
Association of Cannabinoid Administration With Experimental Pain in Healthy Adults: A Systematic Review and Meta-analysis.大麻素给药与健康成年人实验性疼痛的关联：系统评价和荟萃分析。
JAMA Psychiatry. 2018 Nov 1;75(11):1118-1127. doi: 10.1001/jamapsychiatry.2018.2503.
4
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.大麻二酚调节血清素传递，逆转神经病理性疼痛模型中的痛觉过敏和焦虑样行为。
Pain. 2019 Jan;160(1):136-150. doi: 10.1097/j.pain.0000000000001386.
5
Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies.大麻和大麻素治疗慢性非癌症疼痛患者：对照和观察性研究的系统评价和荟萃分析。
Pain. 2018 Oct;159(10):1932-1954. doi: 10.1097/j.pain.0000000000001293.
6
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.大麻素受体和内源性大麻素系统：中枢神经系统中的信号传递和功能。
Int J Mol Sci. 2018 Mar 13;19(3):833. doi: 10.3390/ijms19030833.
7
Practical considerations in medical cannabis administration and dosing.医疗大麻给药和剂量方面的实际考虑因素。
Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4.
8
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.目前在临床前和人体实验环境中获得的基于大麻素的镇痛的证据。
Eur J Pain. 2018 Mar;22(3):471-484. doi: 10.1002/ejp.1148. Epub 2017 Nov 21.
9
An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors.非CB、非CB大麻素相关G蛋白偶联受体的最新进展。
Cannabis Cannabinoid Res. 2017 Oct 1;2(1):265-273. doi: 10.1089/can.2017.0036. eCollection 2017.
10
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.大麻类药物治疗慢性疼痛管理的疗效、耐受性和安全性 - 系统评价概述。
Eur J Pain. 2018 Mar;22(3):455-470. doi: 10.1002/ejp.1118. Epub 2017 Oct 15.
Zotero 插件